neobookRx
GuidelinesOther guideline

Management of Diabetic Foot Ulcers

Management of Diabetic Foot Ulcers

Determine causes

Clinical grading

Ulcer treatment 


DETERMINE CAUSES 
e.g. Ill fitting shoes

CLINICAL GRADING (e.g. University of Texas grading system)

A - D: No infections or ischaemia (A), Infections (B), Ischaemia (C), Both (D).

0 - III: Epithelialized (0), Superficial (I), penetrates to tendon or capsule (II), penetrates to bone or joint (III).

ULCER TREATMENT 

Relief of Pressure 

  • Non weight bearing is essential 
  • Mechanical unloading   

Restoration of Skin Perfusion

  • Arterial revascularisation procedures if required 
  • Treat smoking, hypertension and dyslipidemia 

Treatment of infection

Superficial Ulcer

  • Extensive debridement with removal of all necrotic tissue and oral antibiotics aimed at Staphylococci aureus and streptococci. No topical antibiotics 

Deep (Limb-Threatening) infections 

  • Surgical drainage as soon as possible (emergency referral) with removal if necrotic or poorly vascularised tissue, including infected bone. Revascularisation if necessary. Broad-spectrum antibiotics intravenously aimed at Gram-positive and negative micro-organisms, including anaerobes

Metabolic Control and Treatment of Comorbidity

Optimal diabetes control, if necessary with insulin. Treat oedema and malnutrition 

Local Wound Care

  • Frequent wound inspection
  • Frequent wound debridement 
  • Absorbent, non- adhesive, non- occulusive dressings
  • Foot baths are contra-indications as they induce maceration of the skin

Instruction of Patient and Relatives

Appropriate self- care and recognition, as well as reporting of signs and symptoms of (worsening) infection, such as fever, changes in local wound conditions or hyperglycemia 

Determine the cause and preventing recurrence

Determine cause as ulceration is a recurrent disease. Prevent ulcers on contralateral foot and give heel protection during bed rest. Patient must be included in a comprehensive foot-care program with life-long observation

 

NeoHealth® ID 19098 · updated 10/26/2021